Can a simple finger sensor predict tissue health in septic shock?
NCT ID NCT07330908
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether the dose of norepinephrine, a drug used to raise blood pressure, changes how well a non-invasive finger sensor (peripheral perfusion index) can predict tissue health in 80 septic shock patients. Researchers compared two dose levels to see if the sensor's accuracy varied. The goal is to find better ways to monitor critically ill patients.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- norepinephrine
- What this could lead to
- If successful, this could help doctors better monitor tissue health in septic shock patients, potentially improving treatment decisions.
- What could go wrong
- This is a small, completed study with only 80 participants. Results may not apply to all patients, and the findings are about monitoring, not a new treatment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PERIPHERAL PERFUSION INDEX are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Tanta University
Tanta, Egypt
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Blood markers may foretell brain fog after sepsis
- Can tracking immune chaos in sepsis reveal new treatment targets?
- Blood clot score may predict organ damage in septic shock
- Could a key hormone be missing in septic shock?
- Could a simple mineral cut the need for powerful blood-pressure drugs in septic shock?
- Blood filter could shield vessels in septic shock